| Methods |
Randomised controlled trial reported in German.
Blinding: unclear
Loss to follow‐up: 3(15%) in placebo group and and 6(30%) in steroid injection group did not participate in follow up
Appropriate statistical analysis: not intention to treat analysis, completers analysis only |
| Participants |
40 patients
Inclusion criteria:
chronic painful shoulder caused by chronic subacromial bursitis or supraspinatus tendinitis ‐ criteria for diagnoses not reported
Exclusion criteria:
not stated |
| Interventions |
Group 1(20 patients): 5ml 0.5% mepivacainhydrochloride (MVH)
injection
Group 2(20 patients): 5ml 0.5% MVH plus 20mg triamcinolone hexacetonid (THA) injection |
| Outcomes |
Assessed at baseline, 14, 90 and 360 days
1) Pain (either no pain, low pain, strong pain, very strong pain)
2) angle of abduction reported by patient after eduction in front of a mirror
3) work status |
| Notes |
Met inclusion criteria for review but insufficient data presented (ie. no measure of variance or data from which it could be calculated), therefore not included in meta‐analysis.
Reported greater reduction in pain in placebo group at 90 and 360 days but more patients in treated group were able to work after one year. |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Unclear risk |
B ‐ Unclear |
